Cargando…

Structure-Guided Computational Methods Predict Multiple Distinct Binding Modes for Pyrazoloquinolinones in GABA(A) Receptors

Pyrazoloquinolinones (PQs) are a versatile class of GABA(A) receptor ligands. It has been demonstrated that high functional selectivity for certain receptor subtypes can be obtained by specific substitution patterns, but so far, no clear SAR rules emerge from the studies. As is the case for many GAB...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabjan, Jure, Koniuszewski, Filip, Schaar, Benjamin, Ernst, Margot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844064/
https://www.ncbi.nlm.nih.gov/pubmed/33519364
http://dx.doi.org/10.3389/fnins.2020.611953
_version_ 1783644261609111552
author Fabjan, Jure
Koniuszewski, Filip
Schaar, Benjamin
Ernst, Margot
author_facet Fabjan, Jure
Koniuszewski, Filip
Schaar, Benjamin
Ernst, Margot
author_sort Fabjan, Jure
collection PubMed
description Pyrazoloquinolinones (PQs) are a versatile class of GABA(A) receptor ligands. It has been demonstrated that high functional selectivity for certain receptor subtypes can be obtained by specific substitution patterns, but so far, no clear SAR rules emerge from the studies. As is the case for many GABA(A) receptor targeting chemotypes, PQs can interact with distinct binding sites on a given receptor pentamer. In pentamers of αβγ composition, such as the most abundant α1β2γ2 subtype, many PQs are high affinity binders of the benzodiazepine binding site at the extracellular α+/γ2− interfaces. There they display a functionally near silent, flumazenil-like allosteric activity. More recently, interactions with extracellular α+/β− interfaces have been investigated, where strong positive modulation can be steered toward interesting subtype preferences. The most prominent examples are functionally α6-selective PQs. Similar to benzodiazepines, PQs also seem to interact with sites in the transmembrane domain, mainly the sites used by etomidate and barbiturates. This promiscuity leads to potential contributions from multiple sites to net modulation. Developing ligands that interact exclusively with the extracellular α+/β− interfaces would be desired. Correlating functional profiles with binding sites usage is hampered by scarce and heterogeneous experimental data, as shown in our meta-analysis of aggregated published data. In the absence of experimental structures, bound states can be predicted with pharmacophore matching methods and with computational docking. We thus performed pharmacophore matching studies for the unwanted sites, and computational docking for the extracellular α1,6+/β3− interfaces. The results suggest that PQs interact with their binding sites with diverse binding modes. As such, rational design of improved ligands needs to take a complex structure-activity landscape with branches between sub-series of derivatives into account. We present a workflow, which is suitable to identify and explore potential branching points on the structure-activity landscape of any small molecule chemotype.
format Online
Article
Text
id pubmed-7844064
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78440642021-01-30 Structure-Guided Computational Methods Predict Multiple Distinct Binding Modes for Pyrazoloquinolinones in GABA(A) Receptors Fabjan, Jure Koniuszewski, Filip Schaar, Benjamin Ernst, Margot Front Neurosci Neuroscience Pyrazoloquinolinones (PQs) are a versatile class of GABA(A) receptor ligands. It has been demonstrated that high functional selectivity for certain receptor subtypes can be obtained by specific substitution patterns, but so far, no clear SAR rules emerge from the studies. As is the case for many GABA(A) receptor targeting chemotypes, PQs can interact with distinct binding sites on a given receptor pentamer. In pentamers of αβγ composition, such as the most abundant α1β2γ2 subtype, many PQs are high affinity binders of the benzodiazepine binding site at the extracellular α+/γ2− interfaces. There they display a functionally near silent, flumazenil-like allosteric activity. More recently, interactions with extracellular α+/β− interfaces have been investigated, where strong positive modulation can be steered toward interesting subtype preferences. The most prominent examples are functionally α6-selective PQs. Similar to benzodiazepines, PQs also seem to interact with sites in the transmembrane domain, mainly the sites used by etomidate and barbiturates. This promiscuity leads to potential contributions from multiple sites to net modulation. Developing ligands that interact exclusively with the extracellular α+/β− interfaces would be desired. Correlating functional profiles with binding sites usage is hampered by scarce and heterogeneous experimental data, as shown in our meta-analysis of aggregated published data. In the absence of experimental structures, bound states can be predicted with pharmacophore matching methods and with computational docking. We thus performed pharmacophore matching studies for the unwanted sites, and computational docking for the extracellular α1,6+/β3− interfaces. The results suggest that PQs interact with their binding sites with diverse binding modes. As such, rational design of improved ligands needs to take a complex structure-activity landscape with branches between sub-series of derivatives into account. We present a workflow, which is suitable to identify and explore potential branching points on the structure-activity landscape of any small molecule chemotype. Frontiers Media S.A. 2021-01-15 /pmc/articles/PMC7844064/ /pubmed/33519364 http://dx.doi.org/10.3389/fnins.2020.611953 Text en Copyright © 2021 Fabjan, Koniuszewski, Schaar and Ernst. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Fabjan, Jure
Koniuszewski, Filip
Schaar, Benjamin
Ernst, Margot
Structure-Guided Computational Methods Predict Multiple Distinct Binding Modes for Pyrazoloquinolinones in GABA(A) Receptors
title Structure-Guided Computational Methods Predict Multiple Distinct Binding Modes for Pyrazoloquinolinones in GABA(A) Receptors
title_full Structure-Guided Computational Methods Predict Multiple Distinct Binding Modes for Pyrazoloquinolinones in GABA(A) Receptors
title_fullStr Structure-Guided Computational Methods Predict Multiple Distinct Binding Modes for Pyrazoloquinolinones in GABA(A) Receptors
title_full_unstemmed Structure-Guided Computational Methods Predict Multiple Distinct Binding Modes for Pyrazoloquinolinones in GABA(A) Receptors
title_short Structure-Guided Computational Methods Predict Multiple Distinct Binding Modes for Pyrazoloquinolinones in GABA(A) Receptors
title_sort structure-guided computational methods predict multiple distinct binding modes for pyrazoloquinolinones in gaba(a) receptors
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844064/
https://www.ncbi.nlm.nih.gov/pubmed/33519364
http://dx.doi.org/10.3389/fnins.2020.611953
work_keys_str_mv AT fabjanjure structureguidedcomputationalmethodspredictmultipledistinctbindingmodesforpyrazoloquinolinonesingabaareceptors
AT koniuszewskifilip structureguidedcomputationalmethodspredictmultipledistinctbindingmodesforpyrazoloquinolinonesingabaareceptors
AT schaarbenjamin structureguidedcomputationalmethodspredictmultipledistinctbindingmodesforpyrazoloquinolinonesingabaareceptors
AT ernstmargot structureguidedcomputationalmethodspredictmultipledistinctbindingmodesforpyrazoloquinolinonesingabaareceptors